Finally, the pathogenicity was supported by the results of independent clinical data analysis performed following a standard BRCA1 penetrance model and also after excluding data relating to BC diagnoses, as justified by the penetrance results (Table 3). This evidence concerns the gene BRCA1 and breast cancer.